Sloan Partners LLP wishes Surgically Clean Air Inc. success in raising up to $2,000,000 to further its objective to become a market leader in the premium, stand-alone air purification industry.
SURGICALLY CLEAN AIR INC.
Pursuant to the terms of this Offering Memorandum, the Surgically Clean Air Inc. (the “Issuer” or “SCA”) intends to raise up to CAD $2,000,000 through the issuance of 8,695,653 Common Shares (“Shares”). Up to $240,000.00 will be paid as selling commissions and Offering Expenses resulting in net proceeds of up to $1,7600,000.
The Issuer will use the net proceeds for the purposes of sales and distribution, intellectual protection and portfolio development, product research and development, product production and inventory, brand development and marketing and, general and administration.
SCA aims to become a market leader in the premium, stand-alone air purification industry. Our medical grade air purification systems are suited for use in a range of applications. Currently, hospitals, medical labs, surgery centres, nursing homes, dental offices, funeral homes, professional sports teams, commercial offices, fitness centres, day care centres, universities and residences have selected SCA products.
SCA plans to develop, market and sell its products in Canada, the U.S. and internationally. The objective of the Issuer is to continue to grow the value of its business and thereby increase the value for its shareholders.
Minimum Subscription Amount
The Minimum Subscription Amount is CAD $5,000.00. The Issuer may, at its sole discretion, lower the Minimum Subscription Amount
Selling Agents will be primarily Exempt Market Dealers who will be responsible for the sale of common shares and will be paid a selling commission.
For more information, please contact: Todd Buchanan, Vice-President, Corporate Development
Company website www.surgicallycleanair.com
OFFERING MEMORANDUM DISCLAIMER
This is not a formal offering document. Prospective purchasers of this investment opportunity will be provided with a formal Offering Memorandum dated October 27, 2016 and will need to be qualified for investment prior to making any investment. No person has been authorized to give any information or to make any representation not contained in the formal Offering Memorandum. No securities regulatory authority or regulator has assessed the merits of the proposed offering or reviewed the formal Offering Memorandum. This investment opportunity is speculative and involves a high degree of risk. There is a risk that any investment made will be lost entirely or in part. Only prospective investors who do not require immediate liquidity of their investment and who can afford the loss of their entire investment should consider this investment.